SPONSOR
Georgetown University
Total Trials
7
Recruiting
7
Phases
Phase 2
Conditions studied: Visual Field DefectStrokeHemianopia HomonymousQuadrantanopiaCortical BlindnessVisual Field Defect, PeripheralVisual Field LossTraumatic Brain InjuryBrain TumorThymoma
Georgetown University is a clinical research sponsor with 7 registered studies on ClinicalTrials.gov, of which 7 are actively recruiting participants. Research covers conditions including Visual Field Defect, Stroke, Hemianopia Homonymous, Quadrantanopia.
The trial portfolio spans Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Georgetown University
How many clinical trials has Georgetown University sponsored?
ClinicalMetric currently tracks 7 clinical trials sponsored by Georgetown University, of which 7 are actively recruiting participants. These trials cover conditions including Visual Field Defect, Stroke, Hemianopia Homonymous. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Georgetown University research focus on?
Georgetown University clinical trials span Visual Field Defect, Stroke, Hemianopia Homonymous, Quadrantanopia, Cortical Blindness, and additional conditions. The research pipeline includes Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Georgetown University clinical trial?
To participate in a Georgetown University trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Georgetown University trials with current recruitment status updated daily.
Clinical Trials by Georgetown University
NCT07635329
Recruiting
Home-based Vision Rehabilitation Guided by Brain Imaging
Visual Field Defect
NCT06248515 Phase 2
Recruiting
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors
Thymoma
NCT04675476
Recruiting
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
Lung Cancer
NCT07221747
Recruiting
PathToScale: The PERSIST Trial
Oral Pre-exposure Prophylaxis (PrEP)
NCT07228000
Recruiting
Bundled Cancer Screening and Genetic Services Navigation
Breast Cancer Screening
NCT05130606
Recruiting
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
Hereditary Breast and Ovarian Cancer
NCT06980103
Recruiting
Use of a Decision Aid to Resolve Uncertainty About Radioactive Iodine Treatment in Patients With Intermediate Risk Thyroid Cancer
Thyroid Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology